Managing TKI Adverse Effects: Best Practices for Nilotinib and Other TKIs

Managing TKI Adverse Effects: Best Practices for Nilotinib and Other TKIs

Panelists discuss how managing common adverse events associated with tyrosine kinase inhibitors (TKIs) such as nilotinib requires proactive strategies including supportive medications, dose adjustments, monitoring for gastrointestinal (GI) symptoms, rashes, elevated liver enzymes and glucose metabolism changes, and encouraging patients to maintain ongoing care with their primary care providers for comorbid conditions that could exacerbate potent…